Gerald Walis

Gerald Walis has extensive experience in the field of quality assurance and compliance. Gerald began their career at G&W Laboratories in 2010 as a Quality Assurance and Compliance Specialist. Following this, they worked at Tris Pharma as a Compliance Specialist from November 2013 to November 2014. Gerald then joined Teva/Actavis Generics in April 2012 as a Senior Investigations and CAPA Specialist. Gerald spent a significant portion of their career at Teva/Actavis Generics, staying with the company until December 2017. In December 2017, they joined Cyalume Technologies as the Director of Quality Assurance for a brief period of five months before moving to Hitachi Chemical Advanced Therapeutics Solutions, LLC in May 2018. At Hitachi Chemical, they served as a Quality Assurance Manager until October 2018. Following this, Gerald joined Immunomedics in October 2018 and held the position of Senior Manager for Deviations and CAPAs until November 2019. From November 2019 to August 2021, Gerald worked at Bristol Myers Squibb as the Associate Director and the Global Process Lead for Investigations. Most recently, in August 2021, they joined Elevar Therapeutics as the Director of QA Compliance.

Gerald Walis has a Bachelor of Science degree from the State University of New York College of Environmental Science and Forestry, which they obtained in 2009. Gerald also has a Bachelor of Science degree from Syracuse University, also obtained in 2009.